Study for optimizing the moment of "Adaptive radiotherapy" during curative radiotherapy or radiochemotherapy in Head and Neck cancer

Study for optimizing the moment of "Adaptive radiotherapy" during curative radiotherapy or radiochemotherapy in Head and Neck cancer - Optimizing of Adaptive Radiotherapy or radiochemotherapy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON35249

Enrollment

Registered

2011-12-19

Start date

2012-01-23

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and Neck carcinoma

Interventions

Twice an extra CT scan without contrast

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Signed written Informed Consent - Squamouscell carcinoma in oral cavity, oropharynx, nasopharynx, larynx or hypopharynx - adaptive radiotherapy or radiochemotherapy as primairy treatment

Exclusion criteria

Exclusion criteria: -

Design outcomes

Primary

Measure	Time frame
To investigate the optimal moment of replanning during a curative radio(chemo)therapy treatment in patients with a head and neck tumor	—

Secondary

Measure	Time frame
Analyse if the optimal moment of replanning is depending on tumor location, tumor volume or absolute dose at the OAR	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)